← Leaderboards
Daniel M. Skovronsky
Avid Radiopharmaceuticals, Inc.
$1,503,358
Attributed
$1,753,358
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $756.9K · FY2007–09$1M$750K$500K$250K$0
'07
'08
'09
Funding mix
By agency
NIH$1,753,358 · 4
By mechanism
R43$1,253,358 · 3
R41$500,000 · 1
Top collaborators
- Michael W Weiner2 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposLabelBinding (Molecular Function)GrantImagePositron-Emission TomographyClinical TrialsRadiopharmaceuticalsDiagnosisS DiseaseSenile PlaquesAmyloidMild Cognitive ImpairmentAmyloid ImagingDementiaBaseHalf-LifeBiological MarkersTracerIn VivoValidationDiagnosticDiagnosis EvaluationBiodistribution
Grant awards (7)
18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment$249,998
R43 · FY2009 · NS · contact PI
Development of Radiopharmaceuticals for Imaging Brain Tau Pathology$249,406
R43 · FY2009 · AG · contact PI
18F-AV-45 PET Imaging of Amyloid in PD with Cognitive Impairment$257,498
R43 · FY2008 · NS · contact PI
Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's$250,000
R41 · FY2008 · AG · contact PI
Development of Radiopharmaceuticals for Imaging Brain Tau Pathology$249,406
R43 · FY2008 · AG · contact PI
Clinical Evaluation of IMPY SPECT for Diagnosis of Alzheimer's$250,000
R41 · FY2007 · AG · contact PI
18F-FP-DTBZ for PET Imaging of Beta Cell Mass in Diabetes$247,050
R43 · FY2007 · DK · contact PI